Evaluation of Preoperative Preparation in Children Undergoing Cardiac Surgery or Catheterization (GETREADY)

February 10, 2026 updated by: Prof. Dr. med. Maren Kleine-Brüggeney, Charite University, Berlin, Germany

Evaluation of the Preoperative Preparation for Pediatric Cardiac Surgery and Pediatric Cardiac Catheterization Procedures

Children undergoing cardiac surgery or cardiac catheterization often experience significant stress and anxiety during the preoperative period. A prospective, observational assessment of the preoperative/ preinterventional phase in 100 children undergoing cardiac surgery or cardiac catheterization at the Deutsches Herzzentrum der Charité demonstrated a considerable proportion of pediatric patients present with clinically relevant levels of anxiety before these procedures. Several aspects of the preoperative workflow were identified as potentially modifiable to improve the preparation of children and their families.

Based on these findings, changes in clinical practice were implemented. These measures aim to create a more supportive environment for children undergoing cardiac interventions or surgery.

The investigators now aim to re-evaluate the current preoperative preparation process for children undergoing cardiac surgery or cardiac catheterization at the Deutsches Herzzentrum der Charité and to assess its impact on preoperative stress and anxiety levels. Another 100 children will be enrolled for this follow-up assessment (100 children assessed at baseline in 2025, 100 children to be assessed in 2026, starting end of January 2026). Anxiety and stress and other patient reported outcome and experience measures as well as procedural and clinical data are assessed using validated questionnaires and CRFs prior to the procedure. The perspectives of parents or legal guardians and members of the clinical care team will also be considered to provide a comprehensive view of the preoperative experience.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • State of Berlin
      • Berlin, State of Berlin, Germany, 10553
        • Recruiting
        • DHZC, Charité Universtiätsmedizin Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children undergoing cardiac surgery or cardiac catheterization.

Description

Inclusion Criteria:

  • All children undergoing cardiac surgery or cardiac catheterization.

Exclusion Criteria:

  • Children who are already intubated or tracheotomized and sedated.
  • Children and families who, due to insufficient language skills and lack of interpreters, cannot be informed about the study and cannot consent, and/or cannot complete the questionnaires.
  • Emergency interventions.
  • Death of the child.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Baseline
100 children assessed in 2025
Follow up
100 children to be assessed in 2026

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parental Separation Anxiety Scale
Time Frame: At handover from ward to anaesthesia-/ cathlab-team
PSAS; Preoperative anxiety level; scale from 1 (not anxious) to 4 (crying, fighting) plus necessity to administer propofol for separation
At handover from ward to anaesthesia-/ cathlab-team

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
University of Michigan Sedation Score
Time Frame: At handover from ward to anaesthesia-/ cathlab-team
UMSS, 5 point score from awake (0) to unarousable (4)
At handover from ward to anaesthesia-/ cathlab-team
Modified Yale Preoperative Anxiety Scale - Short Form
Time Frame: at handover from ward to anaesthesia or cathlab-team
mYPAS-SF; Score across 4 categories, 100 is maximum, 22.9 is minimum, higher scores represent worse measures
at handover from ward to anaesthesia or cathlab-team
Faces scale
Time Frame: At handover from ward to anaesthesia-/ cathlab-team
Faces scale (pictures of different faces) for children to express how they feel
At handover from ward to anaesthesia-/ cathlab-team
VAS anxiety scale
Time Frame: At handover of child from ward to anaesthesia-/ cathlab team
Visual analog scale for children to assess how anxious they feel (0-10), higher scores represent more anxiety
At handover of child from ward to anaesthesia-/ cathlab team
heart rate
Time Frame: At handover from ward to anaesthesia-/ cathlab team
heart rate
At handover from ward to anaesthesia-/ cathlab team
Patient and parent reported outcome and experience measure
Time Frame: Between admission to the ward and handover to anaesthesia/ cathlab-team
experience on the ward
Between admission to the ward and handover to anaesthesia/ cathlab-team
Assessment of preoperative phase and anxiety/ wellbeing of the child by clinicians
Time Frame: From admission to the ward until sedation/ anaesthesia
Assessment by the team of the ward and the anaesthesia-/ cathlab-team
From admission to the ward until sedation/ anaesthesia
Follow up
Time Frame: 2 weeks after surgery / cathlab procedure
Assessment of the preoperative/ preinterventional phase by the child and/ or caregiver via telephone interview 2 weeks after surgery/ cathlab procedure
2 weeks after surgery / cathlab procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 9, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

January 21, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Heart Disease in Children

Subscribe